Adverse Drug Events Reporting | Medscape

Log In Register

Adverse Drug Events Reporting News

Alert Boceprevir May Make Some HIV Drugs Less Effective, FDA Warns The FDA warns clinicians and patients about "important" drug interactions between boceprevir and ritonavir-boosted anti-HIV protease inhibitors.
News Alerts, February 2012
Fatal Adverse Events with Pazopanib, Sorafenib, Sunitinib These targeted therapies represent a major step forward in the treatment of cancer, but are associated with fatal adverse events.
Medscape Medical News, February 2012

AAOS Bisphosphonates Raise Contralateral Atypical Fracture Risk
Medscape Medical News, February 9, 2012
Alert Proton Pump Inhibitors Linked to C difficile Diarrhea
News Alerts, February 8, 2012
Benefits of Statins Outweigh Musculoskeletal Effects
Reuters Health Information, February 7, 2012
FDA Panel Raises Concerns Over ADHD Drug Labeling
Medscape Medical News, February 2, 2012

Adverse Drug Events Reporting Perspectives

The Safety of Re-exposure to Recombinant Human Thrombin Commentary on a study on the immunogenicity and safety of re-exposure to recombinant human thrombin, published December 2011 in the Journal of the American College of Surgeons.
Medscape General Surgery, February 9, 2012
Breast Tenderness and Breast Cancer Risk With ET/EPT Are certain types of hormone therapies more likely than others to cause breast tenderness, and how is that potentially connected to the development of breast cancer in some women? This new report explains.
The North American Menopause Society (NAMS), February 3, 2012

Antipsychotics, Dementia, and Mortality Risk
Medscape Psychiatry, February 1, 2012
Vitamins and Mortality: In Defense of Supplements
Medscape Internal Medicine, February 1, 2012
Bydureon: An Easy, Effective New Treatment for Type 2 Diabetes
Medscape Diabetes & Endocrinology, January 31, 2012
What Role Do Nondihydropyridines Have in Patients With CKD?
Medscape Pharmacists, January 31, 2012

Adverse Drug Events Reporting Journal Articles

Fracture Risk and BMD Reduction Associated With PPIs
Pharmacotherapy, February 5, 2012
Teratogen Use in Women of Childbearing Potential
Journal of the American Board of Family Medicine, May 31, 2011
Spondyloarthropathies: Anti-tumor Necrosis Factor-alpha Agents
Rheumatology, April 25, 2011
High-Dose Escitalopram in Major Depressive Disorder
BMC Psychiatry, April 21, 2011
Carbamazepine and Valproate for Alcohol Withdrawal Syndrome
Alcohol and Alcoholism , April 15, 2011

Adverse Drug Events Reporting From Medscape Education

All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC. This website also contains material copyrighted by 3rd parties.